Csenge Advisory Group’s Biogen BIIB Stock Holding History

Csenge Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,028	Closed	-$276K	–	554
2021 Q1	$276K	Sell	1,028 -233	-18%	-$62.8K	0.03%	403
2020 Q4	$309K	Sell	1,261 -6	-0.5%	-$1.55K	0.04%	315
2020 Q3	$356K	Buy	1,267 +76	+6%	+$21.2K	0.05%	269
2020 Q2	$319K	Buy	+1,191	New	+$358K	0.05%	263
2018 Q4	–	Sell	-305	Closed	-$95K	–	344
2018 Q3	$95K	Buy	+305	New	+$105K	0.04%	240
2018 Q2	–	Sell	-749	Closed	-$205K	–	253
2018 Q1	$205K	Buy	749 +3	+0.4%	+$931	0.07%	256
2017 Q4	$238K	Buy	+746	New	+$239K	0.09%	214

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Csenge Advisory Group's BIIB Position: Q2 2021 in Review

Csenge Advisory Group sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,028 shares — an estimated $276K sold.

Csenge Advisory Group first reported a position in BIIB in Q4 2017 and held it in 7 quarters. The position peaked at $356K in Q3 2020. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Csenge Advisory Group reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Csenge Advisory Group sold 1,028 Biogen shares in Q2 2021, an estimated $276K.
Csenge Advisory Group first reported a position in Biogen in Q4 2017 and held it in 7 quarters.
Csenge Advisory Group's Biogen position peaked at $356K in Q3 2020.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Csenge Advisory Group's 13F filing for Q2 2021, filed 21 Jul 2021.